hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS

hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS

The use of hCG, hCG beta -subunit, as well as fragments and active derivatives thereof, or hCG beta -core in the preparation of a medicament for the prophylaxis and/or the treatment of pathologies requiring inhibition of the matrix metalloprotease (MMP) enzymatic activity. L'invention concerne...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ALBINI, ADRIANA, ORENGO, GIORGIA
Format: Patent
Sprache:eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The use of hCG, hCG beta -subunit, as well as fragments and active derivatives thereof, or hCG beta -core in the preparation of a medicament for the prophylaxis and/or the treatment of pathologies requiring inhibition of the matrix metalloprotease (MMP) enzymatic activity. L'invention concerne l'utilisation de hCG, de hCG beta -sous-unité, ainsi que de fragments et de dérivés actifs de ces derniers, ou de hCG beta -noyau dans la préparation d'un médicament destiné à la prophylaxie et/ou le traitement d'affections nécessitant l'inhibition de l'activité enzymatique de la métalloprotéase de matrice.